08 September 2020>: Clinical Research
Serum-Soluble ST2 Is a Novel Biomarker for Evaluating Left Atrial Low-Voltage Zone in Paroxysmal Atrial Fibrillation
Zefeng Wang 1ACDE , Liting Cheng 1BCD , Junmeng Zhang 1AD , Zhuo Liang 1CD , Ruiqing Dong 2B , Fei Hang 1B , Xinlu Wang 1B , Ziyu Wang 1B , Yongquan Wu 1AD* , Jie Du 3ADE*DOI: 10.12659/MSM.926221
Med Sci Monit 2020; 26:e926221
Figure 3 Grouped according to the size of the LA LVZ. Group A: patients with few or even none LVZ (A) and LA LVZ less than 20% (B). Group B: patients with LVZ greater than 20% (C).